Patents by Inventor Susanne Füssel

Susanne Füssel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RNA-biomarkers for diagnosis of prostate cancer
    Patent number: 10301683
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumor cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: May 28, 2019
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • RNA-biomarkers for diagnosing prostate cancer
    Patent number: 10287634
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumor cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: May 14, 2019
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWAND
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • RNA-biomarkers for diagnosis of prostate cancer
    Patent number: 10196696
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: February 5, 2019
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWAND
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • RNA-biomarkers for diagnosis of prostate cancer
    Patent number: 10196695
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: February 5, 2019
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKER SIGNATURE FOR DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20170362662
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2015
    Publication date: December 21, 2017
    Applicant: FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKERS FOR DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20160312291
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 27, 2016
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKERS FOR DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20160304967
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 20, 2016
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKERS FOR DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20160304965
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 20, 2016
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKERS FOR DIAGNOSING PROSTATE CANCER
    Publication number: 20160304966
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 20, 2016
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • NOVEL RNA-BIOMARKERS FOR DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20160298199
    Abstract: The invention relates to the identification and selection of differentially expressed transcripts (biomarker) in tumour cells. Specific determination of the level of these biomarkers can be used for screening and diagnosis of prostate cancer. Clinical application of assays based on these biomarker help reduce the high number of false positives of current standard screening assays.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 13, 2016
    Inventors: Friedemann Horn, Jörg Hackermüller, Sabina Christ, Kristin Reiche, Manfred Wirth, Michael Fröhner, Susanne Füssel
  • Non-invasive method for diagnosis of prostate cancer
    Patent number: 8697358
    Abstract: The present invention relates on a non-invasive method for diagnosing prostate cancer and/or assessing the risk of a subject acquiring prostate cancer comprising the analysis of the expression of the marker gene hepsin in an urine sample. It further relates on a non-invasive method for diagnosing prostate cancer and/or assessing the risk of a subject acquiring prostate cancer by determining the expression levels of the marker genes hepsin, EZH2, prostein and PCA3.
    Type: Grant
    Filed: December 15, 2010
    Date of Patent: April 15, 2014
    Assignee: Technische Universitaet Dresden
    Inventors: Manfred Wirth, Susanne Fuessel, Rainer Koch
  • NON-INVASIVE METHOD FOR DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20130035250
    Abstract: The present invention relates on a non-invasive method for diagnosing prostate cancer and/or assessing the risk of a subject acquiring prostate cancer comprising the analysis of the expression of the marker gene hepsin in an urine sample. It further relates on a non-invasive method for diagnosing prostate cancer and/or assessing the risk of a subject acquiring prostate cancer by determining the expression levels of the marker genes hepsin, EZH2, prostein and PCA3.
    Type: Application
    Filed: December 15, 2010
    Publication date: February 7, 2013
    Applicant: Technische Universitaet Dresden
    Inventors: Manfred Wirth, Susanne Fuessel, Rainer Koch